Distinct variant of Sweet's syndrome: bortezomib-induced histiocytoid Sweet's syndrome in a patient with multiple myeloma

Int J Dermatol. 2012 Dec;51(12):1491-3. doi: 10.1111/j.1365-4632.2011.05141.x. Epub 2012 Sep 24.
No abstract available

Publication types

  • Case Reports
  • Review

MeSH terms

  • Aged
  • Antineoplastic Agents / adverse effects*
  • Boronic Acids / adverse effects*
  • Bortezomib
  • Humans
  • Male
  • Multiple Myeloma / drug therapy*
  • Pyrazines / adverse effects*
  • Sweet Syndrome / chemically induced*
  • Sweet Syndrome / classification
  • Sweet Syndrome / pathology*

Substances

  • Antineoplastic Agents
  • Boronic Acids
  • Pyrazines
  • Bortezomib